Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 5 October 1999
Vol. 1999, Issue 2, p. tw4
[DOI: 10.1126/stke.1999.2.tw4]


Receptor signaling BAMBI disrupts TGF-β receptor

Growth factors belonging to the TGF-β superfamily, including activin, bone morphogenic protein (BMP), and TGF-β, exert their effects through transmembrane-type receptor serine-threonine kinases. Type I and type II TGF-β receptors form a heterotetrameric complex that, when bound to ligand, intiates receptor autophosphorylation and a signaling cascade. Onichtchouk et al. identified a transmembrane protein in Xenopus laevis that has an extracellular domain similar to that of the type I TGF-β receptor, but lacks the intracellular catalytic domain. The protein, called BAMBI, interfered with activin and BMP signaling in Xenopus embryos and in a mouse cell line. BAMBI inhibited constitutively activated forms of several type I receptors, and also coimmunoprecipitated with type I receptors. BAMBI was also found in receptor complexes containing type I and II receptors. The authors suggest that BAMBI negatively regulates TGF-β signaling by binding to type I receptors and disrupting the formation of receptor complexes.

Onichtchouk, D., Chen, Y-G., Dosch, R., Gawantka, V., Delius, H., Massague, J., and Niehrs, C. (1999) Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 401: 480-485. Online Journal

Citation: BAMBI disrupts TGF-β receptor. Sci. STKE 1999, tw4 (1999).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882